Chapter 33, Ep 3 of 5: Travelers' Diarrhea and Bacterial Toxins

The community-acquired diarrheas separate cleanly once you group by acquisition pattern rather than symptoms, because the exposure history predicts the pathogen and the pathogen predicts the treatment. Travelers' diarrhea selects the empiric antibiotic by region and resistance, while rifaximin stays in the noninvasive niche because it is non-absorbed. Shiga-toxin-producing E. coli flips the rule entirely, since antibiotics release more toxin and loperamide prolongs exposure. Nontyphoidal Salmonella, Shigella, Yersinia, Vibrio, and Listeria each run on their own biology, and the foodborne toxin syndromes are recognized by time to onset that tells you cultures and antibiotics are unnecessary.   Topics covered Acquisition pattern as the organizing principle Travelers' diarrhea and region-based empiric therapy Rifaximin in the noninvasive niche The no-antibiotics-for-EHEC rule and HUS Campylobacter and Salmonella treatment rules Shigella, Yersinia, and Vibrio biology Listeria in special hosts Foodborne toxin syndromes by time to onset   Key decisions Choose empiric travelers' diarrhea therapy by region: azithromycin one gram once or five hundred milligrams daily for three days where Campylobacter and fluoroquinolone resistance dominate, with ciprofloxacin only in low-resistance areas. Reserve rifaximin for afebrile, non-bloody travelers' diarrhea because it is non-absorbed and cannot reach invasive Salmonella, Shigella, or Campylobacter in the lamina propria. Withhold antibiotics and loperamide in suspected Shiga-toxin-producing E. coli and give intravenous hydration with renal monitoring, because both interventions raise hemolytic-uremic syndrome risk. Treat nontyphoidal Salmonella gastroenteritis with antibiotics only when extraintestinal seeding risk exists, such as age extremes, immunocompromise, sickle cell disease, prosthetic grafts, or bacteremia. Treat most Shigella cases with a fluoroquinolone or azithromycin because the low infectious dose makes reducing fecal shedding a public health priority. Treat Vibrio vulnificus sepsis with doxycycline plus a third-generation cephalosporin, and treat invasive Listeria with intravenous ampicillin, adding gentamicin for severe disease or meningitis. Recognize the foodborne toxin syndromes by time to onset and skip stool cultures and antibiotics: one to six hours for Staph aureus and emetic Bacillus cereus, eight to sixteen hours for the diarrheal toxins.   For the full chapter with MCQs, tables, and primary-guideline references, visit www.boardpearls.com. Questions or feedback: [email protected]. (00:00) - Introduction and acquisition pattern (01:05) - Travelers' diarrhea by region (01:55) - Rifaximin and the noninvasive niche (02:53) - The no-antibiotics-for-EHEC rule (04:05) - Campylobacter and the enterocolitis differential (04:57) - Salmonella, Shigella, Yersinia, Vibrio (08:12) - Listeria in special hosts (09:12) - Foodborne toxin syndromes